Translational Neural Devices (R61/R33 - Clinical Trial Optional) (PAR-25-053)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) (PAR-25-122)

Sponsor: National Institutes of Health

Award: Application budgets are limited to $100,000 in direct costs (excluding subcontract F&A) for one year and need to reflect the actual needs of the proposed project.

Due Date: Multiple due dates; see announcement.

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) (PAR-25-024)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) (PAR-24-265)

Sponsor: National Institutes of Health

Award: Applications will be accepted that request a single, commercially available instrument or an integrated instrumentation system. The minimum award is $50,000. There is no upper limit on the cost of the instrument, but the maximum award is $750,000.

Due Date: Multiple due dates; see announcement.

Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed) (PAR-24-268)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) (PAR-24-264)

Sponsor: National Institutes of Health

Award: Applications will be accepted that request a single, commercially available instrument or an integrated instrumentation system. The minimum award is $750,001. There is no upper limit on the cost of the instrument, but the maximum award is $2,000,000.

Due Date: Multiple due dates; see announcement.

Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R01 Clinical Trial Optional) (PAR-25-2

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional) (RFA-MH-26-140)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) (PAR-25-058)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) (PAR-25-059)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) (PAR-25-0

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Notice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) (NOT-OD-25-015)

Sponsor: National Institutes of Health

Due Date: January 24, 2025.

Notice of Special Interest (NOSI): National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32) (NOT-GM-24-056)

Sponsor: National Institute Health

Due Date: First Available Due Date: January 25, 2025. Expiration Date: September 26, 2026.

Emerging Global Leader Award (K43 Independent Clinical Trial Required) (PAR-24-295)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) (PAR-24-296)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.